| EBV + infants (n = 49) | EBV− infants (n = 66) | P value |
---|---|---|---|
Maternal age (years) | 28.0 (23.0–30.5) | 26.5 (24.0–31.3) | 0.847 |
Weight (kg) | 59.5 (54.9–66.8) | 55.5 (51.2–65.4) | 0.049 |
Hemoglobin (g/l) | 10.3 (9.4–11.3) | 10.3 (9.1–11.4) | 0.832 |
HBV infection (n,%) | 3 (6.1 %) | 4 (6.1 %) | 1.000 |
CD4 + count (cells/µl) | 390 (218–490) | 336 (204–468) | 0.655 |
HIV-RNA (logcopies/ml) | 4.08 (3.26–4.68) | 4.10 (3.28–4.60) | 0.779 |
WHO stage (I/II/III–IV) (%) | 77.6/10.2/12.2 | 77.3/19.7/3.0 | 0.423 |
ART duration in pregnancy (weeks) | 10 (7.0–13.0) | 10 (6.0–13.3) | 1.000 |
ART regimen: (n, %) | Â | Â | Â |
 d4T- 3TC-NVP  AZT-3TC-NVP | 26 (53.1 %) 23 (46.9 %) | 37 (56.1 %) 29 (43.9 %) | 0.850 |
Unemployment (n, %) | 32 (65.3 %) | 38 (57.6 %) | 0.444 |
Low educational level(no school or only primary) (n,%) | 38 (77.6 % | 36 (54.5 %) | 0.018 |
No electricity at home (n, %) | 41 (83.7 %) | 49 (74.2 %) | 0.260 |
Vaginal delivery (n, %) | 47 (97.9) | 64 (97) | 1.000 |
Infants weight at birth (Kg)a | 3.2 (2.8–3.5) | 3.2 (2.6–3.5) | 0.562 |
Male/female ratio (%) | 49/51 | 45.5/54.5 | 0.850 |
HIV positive infants (n, %)b | 1 (2.0) | 1 (1.5) | 1.000 |
CMV + infants at 12 monthsc | 12/20 (60 %) | 25/35 (71.4 %) | 0.551 |